Edition:
United States

Cigna Corp (CI.N)

CI.N on New York Stock Exchange

189.36USD
18 Oct 2017
Change (% chg)

$2.16 (+1.15%)
Prev Close
$187.20
Open
$187.85
Day's High
$190.53
Day's Low
$187.85
Volume
269,529
Avg. Vol
356,059
52-wk High
$193.00
52-wk Low
$115.06

Latest Key Developments (Source: Significant Developments)

Cigna says early extinguishment of 1 bln debt to result in one-time after-tax expense
Friday, 29 Sep 2017 04:47pm EDT 

Sept 29 (Reuters) - Cigna Corp :Cigna- Early extinguishment of 1 billion debt to result in one-time after-tax expense of about $210 million to be reported in fiscal quarter ending Sept 30, 2017.Cigna Corp- Charge will not impact company's projected consolidated adjusted income from operations for full year 2017 - SEC filing.  Full Article

India's Cigna TTK Health Insurance says gets regulator nod for raising Cigna Corp stake in JV
Thursday, 28 Sep 2017 10:46am EDT 

Sept 28 (Reuters) - * India's Cigna TTK Health Insurance Says Gets Insurance Regulator Nod For Increasing Cigna Corp's stake in JV to 49 percent from 26 percent:.  Full Article

Rennova Health's Labs win appeal in the Eleventh Circuit Court Of Appeals in CIGNA suit
Monday, 25 Sep 2017 09:20am EDT 

Sept 25 (Reuters) - Rennova Health Inc ::Rennova Health's Labs win appeal in the Eleventh Circuit Court Of Appeals in CIGNA suit.Rennova Health Inc - ‍received a favorable decision from Eleventh Circuit Court Of Appeals reversing an earlier decision by U.S. District Court​.  Full Article

Cigna announces tender offers for up to $1 bln in aggregate principal amount of certain series of its outstanding senior notes
Tuesday, 5 Sep 2017 09:20am EDT 

Sept 5 (Reuters) - Cigna Corp ::Cigna announces tender offers for up to $1 billion in aggregate principal amount of certain series of its outstanding senior notes.Cigna Corp - ‍tender offers will expire at 11:59 p.m., New York City time, on October 2, 2017​.Cigna Corp- commenced an offer to purchase for cash up to aggregate maximum principal amount of its outstanding 8.300% notes due 2023.Cigna Corp- also commenced an offer to purchase 7.650% notes due 2023, 7.875% debentures due 2027, 8.300% step down notes due 2033.Cigna Corp- also commenced an offer to purchase 6.150% notes due 2036, 5.875% notes due 2041 and 5.375% notes due 2042.  Full Article

Cigna files preliminary prospectus supplement for potential senior notes offering
Tuesday, 5 Sep 2017 09:05am EDT 

Sept 5 (Reuters) - Cigna Corp ::Cigna Corp files preliminary prospectus supplement for potential senior notes offering; size not disclosed - SEC filing‍​.  Full Article

Cigna says to reaffirm projected FY 2017 consolidated adjusted income from operations, which remains in range of $2.50 - $2.58 bln - SEC Filing
Monday, 28 Aug 2017 06:21am EDT 

Aug 28 (Reuters) - Cigna Corp :Cigna Corp says to reaffirm projected FY 2017 consolidated adjusted income from operations, which remains in range of $2.50 - $2.58 billion - SEC Filing.  Full Article

Cigna files for potential mixed shelf
Friday, 4 Aug 2017 05:40pm EDT 

Aug 4 (Reuters) - Cigna Corp -:Cigna Corp files for potential mixed shelf, size not disclosed - sec filing‍​.  Full Article

Cigna Corp Q2 adjusted operating earnings per share $2.91
Friday, 4 Aug 2017 06:00am EDT 

Aug 4 (Reuters) - Cigna Corp :Cigna reports strong second quarter 2017 results, raises outlook.Q2 adjusted operating earnings per share $2.91.Q2 revenue $10.3 billion versus I/B/E/S view $10.27 billion.Q2 earnings per share view $2.48 -- Thomson Reuters I/B/E/S.Q2 earnings per share $3.15.Sees FY 2017 adjusted operating earnings per share $9.75 to $10.05.Cigna Corp sees ‍2017 total revenue growth 3% to 4%​.Cigna Corp - sees 2017 total government medical care ratio ‍84.5% to 85.5%​.Cigna Corp sees FY total commercial medical care ratio ‍80.5% to 81.5%​.Cigna Corp - sees 2017 global health care operating expense ratio ‍20.5% to 21.5%​.Cigna Corp qtrly global health care net medical costs payable was approximately $2.59 billion at June 30, 2017 and $2.26 billion at December 31, 2016‍​.Cigna Corp sees 2017 ‍global medical customer growth between 500,000 to 600,000 customers​.Cigna Corp - ‍Q2 2017 shareholders' net income included a special item benefit of $47 million after-tax, or $0.18 per share​.Cigna Corp - ‍Q2 2017 shareholders' net income included a special item associated with terminated merger agreement with Anthem​.FY2017 earnings per share view $9.79, revenue view $41.10 billion -- Thomson Reuters I/B/E/S.  Full Article

Interpace Diagnostics says Cigna agreed to cover co's ThyGenx test for Cigna members
Thursday, 27 Jul 2017 08:00am EDT 

July 27 (Reuters) - Cigna Corp :Interpace diagnostics group inc - cigna agreed to cover interpace's thygenx test for cigna members nationwide, with coverage effective immediately.  Full Article

Cigna sees FY2017 adjusted income from operations of $9.35/shr-$9.85/shr​
Wednesday, 21 Jun 2017 06:15am EDT 

June 21 (Reuters) - Cigna Corp ::Says ‍now expects full year 2017 adjusted income from operations per share in range of $9.35 to $9.85​.Cigna Corp - expect to reaffirm projected full year 2017 consolidated adjusted income from operations, which remains in range of $2.41 billion to $2.53 billion.FY 2017 earnings per share view $9.73 -- Thomson Reuters I/B/E/S.  Full Article

Photo

Cigna to end OxyContin painkiller coverage, signs contract for alternative

Amid a growing U.S. opioid addiction, health insurer Cigna Corp will stop covering OxyContin, the opioid painkiller sold by Purdue Pharma LP, as of Jan. 1 and will instead cover an equivalent with a formulation less vulnerable to abuse, the company said on Wednesday.